Sign up
Pharma Capital

Alpha Tau Medical says its cancer therapy dissolves solid tumors in days

Alpha Tau Medical Board Member Howard David Sterling spoke with Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.

Alpha Tau Medical is an Israeli MedTech company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.


View full ALPHA profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.